Igor Khandros, Nutcracker Therapeutics CEO
GMP-in-a-box company with Bob Nelsen backing lands $167M to develop its own cancer drugs
For the fourth time in as many weeks, a company focused on portable drug manufacturing is making noise.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
